Psilo Pharma Inc.
  • About
  • Team
  • Partners
  • Market Insights
  • Contact Us
Select Page

What Canada’s special access program means for patients and doctors

by admin | Jan 29, 2022 | Insights

An update from Canada: While many have welcomed the changes to Canada’s SAP program with open arms, some advocates say the program doesn’t go far enough. #psychedelicsaroundtheworld #Canada #SAP #psychedelicscience #psilocybin #psychedelictherapy
 
Link to post
Link to article
COPYRIGHT © 2021 PSILO PHARMA INC. ALL RIGHTS RESERVED.